As of 4:14pm ET
| -0.10 / -0.46%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 21.38, with a high estimate of 21.75 and a low estimate of 21.00. The median estimate represents a -1.09% decrease from the last price of 21.61.
The current consensus among 3 polled investment analysts is to Hold stock in Albany Molecular Research Inc. This rating has held steady since June, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.